BriaCell Therapeutics Investor Presentation October 2023
Loading viewer...
investor_presentation
Format: PDF investor_presentation
BriaCell Therapeutics is developing novel immunotherapies to fight cancer and improve patients' lives. The company, trading on Nasdaq under ticker BCTX and on TSX as BCT, is focused on creating innovative cancer therapeutics through advanced drug development programs.
